Company intelligence / Profile preview

Gentuity

Sudbury, Massachusetts, United Statesgentuity.com ↗

Ownership: Private
Employees: ~88
Development stage: Commercial

Overview

Gentuity has developed and commercialized the first FDA-cleared intravascular imaging platform specifically indicated for both pre-and post-coronary intervention vessel assessment. Its Vis-Rx micro-imaging catheter is the world’s smallest at 1.8F, enabling high-resolution imaging of coronary arteries without pre-dilation, streamlining workflow and improving procedural accuracy. Clinical studies show that pre-procedural OCT imaging with this system led to changes in strategy in 80% of lesions[3][7].

Therapeutic areas: Cardiovascular
Modalities: DeviceImaging system (High-Frequency Optical Coherence Tomography)
Industry: Medical Imaging

Partnerships

Nipro Medical Corporation (global distribution partner)[1][7]

Beyond the preview

Go deeper on Gentuity.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gentuity.

Explore the full profile